Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review
- PMID: 25022716
- PMCID: PMC4986511
- DOI: 10.1007/s00405-014-3104-5
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review
Abstract
Prophylactic neck dissection (PND) for papillary thyroid carcinoma (PTC) is controversial. Our aim was to assess current levels of evidence (LE) according to the Oxford Centre for Evidence-based Medicine ( http://www.cebm.net/?O=1025 ) regarding the oncologic benefits of PND. Data were analyzed via MEDLINE keywords: PTC, differentiated thyroid carcinoma, PND, central lymph node metastases, central compartment, recurrence-free survival. There was conflicting evidence regarding the rate of reoperation for recurrence, with some studies showing a lower rate after PND with increased recurrence-free survival and a higher rate of undetectable pre- and post-ablation thyroglobulin levels (LE 4), whereas other studies did not show a difference (LE 4). Only one study (LE 4) showed improved disease-specific survival with PND. PND may improve recurrence-free survival, although this is supported by only a low LE. Current recommendations can only be based on low-level evidence.
Similar articles
-
Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.World J Surg Oncol. 2016 Sep 19;14(1):247. doi: 10.1186/s12957-016-1003-5. World J Surg Oncol. 2016. PMID: 27644091 Free PMC article. Review.
-
Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.Int J Surg. 2017 May;41 Suppl 1:S40-S47. doi: 10.1016/j.ijsu.2017.01.113. Int J Surg. 2017. PMID: 28506412
-
Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis.Braz J Otorhinolaryngol. 2019 Mar-Apr;85(2):237-243. doi: 10.1016/j.bjorl.2018.05.004. Epub 2018 Jun 20. Braz J Otorhinolaryngol. 2019. PMID: 30017872 Free PMC article.
-
Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.Surgery. 2017 Feb;161(2):465-471. doi: 10.1016/j.surg.2016.07.031. Epub 2016 Aug 26. Surgery. 2017. PMID: 27574773
-
Surgical approach to level VI in papillary thyroid carcinoma: an overview.Updates Surg. 2017 Jun;69(2):205-209. doi: 10.1007/s13304-017-0468-2. Epub 2017 Jun 13. Updates Surg. 2017. PMID: 28612210 Review.
Cited by
-
Is Performance of Routine Central Compartment Neck Dissection in cN0 Papillary Thyroid Cancers Really Useful? 10-Year Prospective Observational Study.Indian J Surg Oncol. 2022 Mar;13(1):152-156. doi: 10.1007/s13193-021-01408-3. Epub 2021 Sep 1. Indian J Surg Oncol. 2022. PMID: 35462667 Free PMC article.
-
Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups.Front Endocrinol (Lausanne). 2022 Feb 17;13:807431. doi: 10.3389/fendo.2022.807431. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35250865 Free PMC article.
-
Dual-energy computed tomography could reliably differentiate metastatic from non-metastatic lymph nodes of less than 0.5 cm in patients with papillary thyroid carcinoma.Quant Imaging Med Surg. 2021 Apr;11(4):1354-1367. doi: 10.21037/qims-20-846. Quant Imaging Med Surg. 2021. PMID: 33816174 Free PMC article.
-
Effect of prophylactic central neck dissection on the surgical outcomes in papillary thyroid cancer: experience in a single center.Eur Arch Otorhinolaryngol. 2020 May;277(5):1491-1497. doi: 10.1007/s00405-020-05830-1. Epub 2020 Feb 12. Eur Arch Otorhinolaryngol. 2020. PMID: 32052141
-
Carbon nanoparticles guide contralateral central neck dissection in patients with papillary thyroid cancer.Oncol Lett. 2018 Jul;16(1):447-452. doi: 10.3892/ol.2018.8691. Epub 2018 May 10. Oncol Lett. 2018. PMID: 29963128 Free PMC article.
References
-
- Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62:220–241. - PubMed
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Podnos YD, Smith D, Wagman LD, Ellenhorn JD. The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg. 2005;71:731–734. - PubMed
-
- Zaydfudim V, Feurer ID, Griffin MR, Phay JE. The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery. 2008;144:1070–1077. discussion 1077–1078. - PubMed
-
- Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–1214. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
